Pharmacokinetic study of harmane and its 10 metabolites in rat after intravenous and oral administration by UPLC-ESI-MS/MS

References

• Alves RC, Casal S, Oliveira BPP. 2007. Factors influencing the norharman and harman contents in espresso coffee. J Agric Food Chem. 55:1832–1838.
   PubMed Web of Science ®Google Scholar
• Anderson NJ, Robinson ESJ, Husbands SM, Delagrange P, Nutt DJ, Hudson AL. 2003. Characterization of [3H]harmane binding to rat whole brain membranes. Ann N Y Acad Sci. 1009:175–179.
   PubMed Web of Science ®Google Scholar
• Anderson NJ, Tyacke RJ, Husbands SM, Nutt DJ, Hudson AL, Robinson ESJ. 2006. In vitro and ex vivo distribution of [3H]harmane, an endogenousbeta-carboline, in rat brain. Neuropharmacology 50:269–76.
   PubMed Web of Science ®Google Scholar
• Arib O, Rat P, Molimard R, Chait A, Faure P, Beaurepaire R. 2010. Electrophysiological characterization of harmane-induced activation of mesolimbic dopamine neurons. Eur J Pharmacol. 629:47–52.
   PubMed Web of Science ®Google Scholar
• Guan J, Zhao Y, Zhu HY, An ZZ, Yu YM, Li RJ, Yu ZG. 2014. A rapid and sensitive UHPLC-MS/MS method for quantification of 2-(2-hydroxypropanamido) benzoic acid in rat plasma: application to a pharmacokinetic study. J Pharm Biomed Anal. 95:20–25.
   PubMed Web of Science ®Google Scholar
• Guan YB, Louis ED, Zheng W. 2001. Toxicokinetics of tremorogenic natural products, harmane and harmine, in male Sprague–Dawley rats. J Toxicol Environ Health Part A 64:645–660.
   PubMed Web of Science ®Google Scholar
• Hu ZY, Parker RB, Herring VL, Casey Laizure S. 2013. Conventional liquid chromatography/triple quadrupole mass spectrometry based metabolite identification and semi-quantitative estimation approach in the investigation of in vitro dabigatran etexilate metabolism. Anal Bioanal Chem. 405:1695–1704.
   PubMed Web of Science ®Google Scholar
• Kuhn W, Müller T, Grosse H, Rommelspacher H. 1995. Plasma harman and norharman in Parkinson's disease. J Neural Transm. 46:291–295.
   Google Scholar
• Li SP, Liu W, Teng L, Cheng XM, Wang ZT, Wang CH. 2014. Metabolites identification of harmane in vitro/in vivo in rats by ultra-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight tandem mass spectrometry. J Pharm Biomed. 92:53–62.
   PubMed Web of Science ®Google Scholar
• Louis ED, Jiang W, Pellegrino KM, Rios E, Factor-Litvak P, Henchcliffe C, Zheng W. 2008. Elevated blood harmane (1-methyl-9H-pyrido-[3,4-b]-indole) concentrations in essential tremor. Neurotoxicology 29:294–300.
   PubMed Web of Science ®Google Scholar
• Louis ED, Zheng W, Mao XL, Shungu DC. 2007. Blood harmane is correlated with cerebellar metabolism in essential tremor: a pilot study. Neurology 69:515–520.
   PubMed Web of Science ®Google Scholar
• Louis ED, Zheng W, Applegate L, Shi L, Factor-Litvak P. 2005. Blood harmane concentrations and dietary protein consumption in essential tremor. Neurology 65:391–396.
   PubMed Web of Science ®Google Scholar
• Nasehi M, Piri M, Nouri M, Farzin D, Nayer-Nouri T, Zarrindast MR. 2010. Involvement of dopamine D1/D2 receptors on harmane-induced amnesia in the step-down passive avoidance test. Eur J Pharmacol. 634:77–83.
   PubMed Web of Science ®Google Scholar
• Ostergren A, Annas A, Skog K. 2004. Long-term retention of neurotoxic beta-carbolines in brain neuromelanin. J Neural Transm (Vienna). 111:141–157.
   PubMed Web of Science ®Google Scholar
• Pfau W, Skog K. 2004. Exposure to beta-carbolines norharman and harman. J Chromatogr B Analyt Technol Biomed Life Sci. 802:115–126.
   PubMed Web of Science ®Google Scholar
• Piletz JE, Zhu H, Ordway G, Stockmeiera C, Dillyd G, Reise D, Halaris A. 2000. Imidazoline receptor proteins are decreased in the hippocampus of individuals with major depression. Biol Psychiatry 48:910–919.
   PubMed Web of Science ®Google Scholar
• Poindexter EH Jr, Carpenter RD. 1962. The isolation of harmane and norharmane from tobacco and cigarette smoke. Phytochemistry 1:215–221.
   Web of Science ®Google Scholar
• Rommelspacher H, Schmidt LG, May T. 1991. Plasma norharman (beta-carboline) levels are elevated in chronic alcoholics. Alcohol Clin Exp Res. 15:553–559.
   PubMed Web of Science ®Google Scholar
• Serra PA, Pluchino S, Marchetti B, Desole MS, Miele E. 2008. The MPTP mouse model: cues on DA release and neural stem cell restorative role. Parkinsonism Relat D 14:189–193.
   Google Scholar
• Spijkerman R, Vanden Eijnden R, Vanden Mheen D, Bongers I, Fekkes D. 2002. The impact of smoking and drinking on plasma levels of norharman. Eur Neuropsychopharmacol. 12:61–71.
   PubMed Web of Science ®Google Scholar
• Squires PE, Hills CE, Rogers GJ, Garland P, Farley SR, Morgan NG. 2004. The putative imidazoline receptor agonist, harmane, promotes intracellular calcium mobilisation in pancreaticbeta-cells. Eur J Pharmacol. 501:31–39.
   PubMed Web of Science ®Google Scholar
• Stohler R, Rommelspacher H, Ladewig D. 1995. The role of beta-carbolines (harman/norharman) in heroin addicts. Eur Psychiatry 10:56–58.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. 2001. Guidance for industry: bioanalytical method validation. USA: Centre for Drug Evaluation and Research.
   Google Scholar
• Wang CH, Li Y, Gao JG, He YQ, Xiong AZ, Yang L, Cheng XM, Ma YM, Wang ZT. 2011. The comparative pharmacokinetics of two pyrrolizidine alkaloids, senecionine and adonifoline, and their main metabolites in rats after intravenous and oral administration by UPLC/ESIMS. Anal Bioanal Chem. 401:275–287.
   PubMed Web of Science ®Google Scholar
• Yang YD, Cheng XM, Liu W, Chou GX, Wang ZT, Wang CH. 2015. Potent AChE and BChE inhibitors isolated from seeds of Peganum harmala Linn by a bioassay-guided fractionation. J Ethnopharmacol. 168:279–286.
   PubMed Web of Science ®Google Scholar
• Yu AM, Idle JR, Kausz KW, Kupfer A, Gonzalez FJ. 2003. Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine. J Pharmacol Exp Ther. 305:315–322.
   PubMed Web of Science ®Google Scholar
• Zeng S, Zhou Q, Yu LS, Chen SQ. 2008. Drug metabolism. China: Zhejiang University Publisher.
   Google Scholar
• Zetler G, Singbartl G, Schlosser L. 1972. Cerebral pharmacokinetics of tremor-producing harmala and iboga alkaloids. Pharmacology 7:237–248.
   PubMed Web of Science ®Google Scholar
• Zhao T, Ding KM, Zhang L, Cheng XM, Wang CH, Wang ZT. 2013. Acetylcholinesterase and butyrylcholinesterase inhibitory activities of β-carboline and quinoline alkaloids derivatives from the plants of genus Peganum. J Chem. 2013:1–6.
   Web of Science ®Google Scholar